Pfizer Inc
NYSE: PFE
$25.65
+$0.52 (+2.1%)
Closing Price on November 22, 2024
PFE Articles
Pfizer Inc. (NYSE: PFE) was printing money during the Covid pandemic. Still, those days are way in the rearview mirror as investors not only see shrinking sales but also see the potential for a...
Published:
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
Published:
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of 2023 and...
Published:
The stock market for the most part has had a solid year after a dreadful 2022, and those that owned any of the Magnificent 7 have had an incredible year. The reality is that the great majority of the...
Published:
For growth and income investors, it makes sense now to look at blue chip dividend stocks with big and dependable payouts. These six are well suited for what could be a difficult end to 2023 as the...
Published:
Pfizer stock has tumbled due to shrinking vaccine sales and the potential for a social and consumer backlash. Moderna stock has also been pounded.
Published:
Tuesday's top analyst upgrades and downgrades included Colgate-Palmolive, Crown Castle, Dollar General, D.R. Horton, Enphase Energy, Instacart, Netflix, Pfizer, Southern Company, UnitedHealth, Walt...
Published:
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Published:
These five outstanding stocks come with big dividends and some big safety, making them ideal for worried investors looking to hedge or take the money and run to safe havens in what could be a rough...
Published:
After U.S. markets closed on Thursday, Ford beat estimates on both the top and bottom lines, posting a 12% year-over-year increase in revenue and a 5.9% increase in earnings per share (EPS). And even...
Published:
These seven big-dividend stocks offer growth if the market continues higher, but also a degree of safety if the AI-driven bubble bursts and market declines and volatility return, as J.P. Morgan warns...
Published:
Friday's top analyst upgrades and downgrades included Citizens Financial, Eaton, Freeport-McMoRan, General Mills, Graphic Packaging, Micron Technology, Mosaic, Netflix, Pfizer, Roku, Ross Stores and...
Published:
With money market and certificate of deposit rates over 4% and interest rate hikes winding down, it makes sense now for growth and income investors to look at blue chip stocks with big and dependable...
Published:
Friday's top analyst upgrades and downgrades included Albemarle, Alcoa, Alphabet, Block, CF Industries, Kraft Heinz, Livent, Mosaic, Norfolk Southern, Pfizer, RingCentral, Roblox, StoneCo, Trade...
Published:
Before U.S. markets open on Tuesday, these four companies are scheduled to release quarterly earnings reports.
Published: